Insider: Akinsanya Karen President of R&D, Therapeutics - Schrodinger, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 23,970 | 0 | 23,970 |
| Value | $462,621.00 | $0.00 | $462,621.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 04/14/2025 | DDS | 8,378 | Direct | COM | $25.11 | $210,390.85 | 23,970 |
| 04/14/2025 | DDS | 5,000 | Direct | COM | $25.11 | $125,554.50 | 18,970 |
| 04/14/2025 | DDS | 3,345 | Direct | COM | $25.00 | $83,625.00 | 15,625 |
| 10/15/2021 | DDS | 1,393 | Direct | COM | $55.75 | $77,659.75 | 0 |
| 09/15/2021 | DDS | 1,394 | Direct | COM | $61.13 | $85,215.22 | 0 |
| 08/16/2021 | DDS | 16,047 | Direct | COM | $58.17 | $933,526.20 | 0 |
| 08/16/2021 | DDS | 21,691 | Direct | COM | $57.43 | $1,245,787.88 | 16,047 |
| 12/18/2020 | DDS | 13,377 | Direct | COM | $80.00 | $1,070,160.00 | 0 |
| 08/17/2020 | DDS | 334 | Direct | COM | $68.81 | $22,982.17 | 100 |
| 08/17/2020 | DDS | 2,910 | Direct | COM | $67.88 | $197,533.42 | 434 |
| 08/17/2020 | DDS | 100 | Direct | COM | $70.04 | $7,004.00 | 0 |
| 08/12/2020 | DDS | 2,641 | Direct | COM | $68.18 | $180,065.23 | 6,688 |
| 08/12/2020 | DDS | 7,839 | Direct | COM | $67.35 | $527,932.35 | 9,329 |
| 08/12/2020 | DDS | 2,697 | Direct | COM | $66.53 | $179,419.81 | 17,168 |
| 08/12/2020 | DDS | 200 | Direct | COM | $65.09 | $13,017.00 | 19,865 |
| 08/12/2020 | DDS | 100 | Direct | COM | $65.05 | $6,505.00 | 6,588 |
| 08/12/2020 | DDS | 1,972 | Direct | COM | $67.56 | $133,222.40 | 3,669 |
| 08/12/2020 | DDS | 407 | Direct | COM | $68.17 | $27,746.21 | 0 |
| 08/12/2020 | DDS | 1,861 | Direct | COM | $67.53 | $125,668.12 | 407 |
| 08/12/2020 | DDS | 1,076 | Direct | COM | $66.66 | $71,727.88 | 2,268 |
| 08/12/2020 | DDS | 325 | Direct | COM | $68.41 | $22,233.51 | 3,344 |
| 08/12/2020 | DDS | 947 | Direct | COM | $66.73 | $63,192.46 | 5,641 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research